Dermazor

Product NDC: 63302-202
11-digit product format: 633020202
Labeler code: 63302
Product ID: 63302-202_2a846da9-2949-418e-b0c4-0eb2f0a58301
Type: HUMAN OTC DRUG
Nonproprietary name: Salicylic Acid, Zinc Oxide
Dosage form: CREAM
Route: TOPICAL
Labeler: PRESTIGIO LTD
Application: part358H
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2014-05-05
Marketing end: 0000-00-00
Substance: SALICYLIC ACID
Active strength: 3 g/100g
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	63302-202		I	Inactivated by FDA	2026-10-20
excluded package	package	63302-202	63302-202-01	I	Inactivated by FDA	2026-10-20
excluded package	package	63302-202	63302-202-02	I	Inactivated by FDA	2026-10-20

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 54 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63302-202-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63302-202-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63302-202-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63302-202-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63302-202-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63302-202-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63302-202-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63302-202-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63302-202-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63302-202-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63302-202-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63302-202-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63302-202-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63302-202-02	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63302-202-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63302-202-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63302-202-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63302-202-02	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63302-202-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63302-202-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63302-202-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63302-202-02	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63302-202-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63302-202-02	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	63302-202-01	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	63302-202-02	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	63302-202-01	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	63302-202-02	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	63302-202-01	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	63302-202-02	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	63302-202-01	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	63302-202-02	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	63302-202-01	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	63302-202-02	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	63302-202-01	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	63302-202-02	`bd6a592717d7…`	`303034d00443…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63302-202-01	2022-01-28	C162847	48780-1	d6a99b39-5168-a426-e053-dadaa90af4c2	Drug Facts
63302-202-02	2022-01-28	C162847	48780-1	d6a99b39-5168-a426-e053-dadaa90af4c2	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
63302-202-01	DermazorPsoriasis and Seborrheic Dermatitis	100 g in 1 TUBE	CREAM	100		5
63302-202-02	DermazorPsoriasis and Seborrheic Dermatitis	100 g in 1 TUBE	CREAM	100		5

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
.ALPHA.-TOCOPHEROL	INACTIVE INGREDIENT	H4N855PNZ1	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
ALMOND OIL	INACTIVE INGREDIENT	66YXD4DKO9	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
BORAGE OIL	INACTIVE INGREDIENT	F8XAG1755S	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
CALENDULA OFFICINALIS FLOWER	INACTIVE INGREDIENT	P0M7O4Y7YD	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
CHIA SEED OIL	INACTIVE INGREDIENT	MC2LH51BO7	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
EVENING PRIMROSE OIL	INACTIVE INGREDIENT	3Q9L08K71N	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
GRAPE SEED OIL	INACTIVE INGREDIENT	930MLC8XGG	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
LANOLIN	INACTIVE INGREDIENT	7EV65EAW6H	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
LAVENDER OIL	INACTIVE INGREDIENT	ZBP1YXW0H8	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
LEVOMENOL	INACTIVE INGREDIENT	24WE03BX2T	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
NIGELLA SATIVA SEED OIL	INACTIVE INGREDIENT	CS4U38E731	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
PETROLATUM	INACTIVE INGREDIENT	4T6H12BN9U	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
SILYBUM MARIANUM SEED OIL	INACTIVE INGREDIENT	NYY23HEN06	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
VITAMIN A	INACTIVE INGREDIENT	81G40H8B0T	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
WHITE WAX	INACTIVE INGREDIENT	7G1J5DA97F	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1
ZINC OXIDE	INACTIVE INGREDIENT	SOI2LOH54Z	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63302-202	DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]	5	Legacy NDC, 2 package rows	20200117_df95a616-714e-4727-af91-1b993a55b661.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
O414PZ4LPZ	SALICYLIC ACID	69-72-7	SALICYLIC ACID

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1537091	Dermazor 3 % Topical Cream	PSN	df95a616-714e-4727-af91-1b993a55b661	5
416910	salicylic acid 3 % Topical Cream	PSN	df95a616-714e-4727-af91-1b993a55b661	5
1537091	salicylic acid 30 MG/ML Topical Cream [Dermazor]	SBD	df95a616-714e-4727-af91-1b993a55b661	5
416910	salicylic acid 30 MG/ML Topical Cream	SCD	df95a616-714e-4727-af91-1b993a55b661	5
1537091	Dermazor 3 % Topical Cream	SY	df95a616-714e-4727-af91-1b993a55b661	5
1537091	Dermazor 30 MG/ML Topical Cream	SY	df95a616-714e-4727-af91-1b993a55b661	5
416910	salicylic acid 3 % Topical Cream	SY	df95a616-714e-4727-af91-1b993a55b661	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63302-202-01	63302020201	100 g in 1 TUBE (63302-202-01)	100 g	2014-05-05	0000-00-00	No	No	Current
63302-202-02	63302020202	100 g in 1 TUBE (63302-202-02)	100 g	2017-08-17	0000-00-00	No	No	Current